|
2025
|
G/S
|
Pharmaceutical and medicinal preparations and substances; vaccines. |
|
|
G/S
|
Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treat... |
|
|
G/S
|
Pharmaceutical and medicinal preparations and substances;
vaccines. |
|
|
G/S
|
Pharmaceutical preparations and substances; medicinal preparations and substances; vaccines. |
|
2024
|
G/S
|
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases;... |
|
|
G/S
|
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tiss... |
|
|
G/S
|
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious disease; ... |
|
|
Invention
|
Recombinant rna molecules comprising untranslated regions or segments encoding spike protein from... |
|
|
G/S
|
Vaccines for human use. |
|
|
Invention
|
Immunogenic compositions.
The invention provides an immunogenic composition comprising OMVs and ... |
|
|
Invention
|
Pre-fusion rsv f antigens.
The invention relates to pre-fusion RSV F protein and polypeptides th... |
|
|
Invention
|
Vaccines for neisseria gonorrhoeae.
A method for immunizing a subject in need thereof against Ne... |
|
|
Invention
|
Modified proteins. Candida albicansCandida albicans') protein. The modified Sap2 protein can be u... |
|
|
Invention
|
Modified proteins. Candida albicansCandida albicans) protein. The modified Als3 protein can be us... |
|
|
Invention
|
Immunogenic compositions and uses thereof.
The present invention is in the field of treating and... |
|
|
Invention
|
Lyophilised composition. The present invention provides lyophilised pharmaceutical compositions a... |
|
|
Invention
|
Immunogenic composition. The present invention relates to immunogenic compositions comprising out... |
|
|
Invention
|
Vaccine. The present invention relates to conjugates comprising polysaccharides comprising 3- deo... |
|
|
Invention
|
Immunogenic composition. S. entericaS.S. Paratyphi A bacterium comprising modified lipid A. |
|
|
Invention
|
Immunogenic composition. The present invention relates to immunogenic compositions comprising ant... |
|
|
Invention
|
Group b streptococcus capsular polysaccharide vaccine and methods of use.
A method of immunizing... |
|
|
Invention
|
Cysteine-substituted rsv-f proteins. inter alia inter alia, an RSV-F protein comprising at least ... |
|
|
Invention
|
Methods for eliciting an immune response to respiratory syncycial virus and streptococcus pneumon... |
|
|
Invention
|
Rsv immunization regimen.
The invention relates to an immunization regimen whereby an infant is ... |
|
|
Invention
|
Rna purification methods.
Methods for purifying RNA from a sample, comprising one or more steps ... |
|
|
Invention
|
Novel methods for manufacturing an adjuvant.
The present invention relates to compositions and m... |
|
|
Invention
|
Modified cytomegalovirus proteins and stabilized complexes.
Described are mutant, human cytomega... |
|
|
Invention
|
Immunogenic composition.
The present invention discloses a recombinant bacteriophage comprising ... |
|
|
Invention
|
Influenza virus vaccines. inter aliainter alia directed to immunogenic compositions for use in th... |
|
|
Invention
|
Influenza virus vaccines. The present invention is inter alia directed to immunogenic composition... |
|
|
Invention
|
Multiple functionalized nomv conjugates.
The present invention is in the field of conjugating na... |
|
|
Invention
|
Hepatitis b immunisation regimen and compositions.
The present invention relates to immunogenic ... |
|
|
Invention
|
Rsv-f-encoding nucleic acids. The present disclosure provides inter alia, a recombinant ribonucle... |
|
|
Invention
|
Process for the manipulation of nucleic acids.
A process for engineering a host cell comprising ... |
|
|
G/S
|
Education services; arranging and conducting of colloquiums, conferences, congresses, seminars, s... |
|
|
Invention
|
Rsv-f-encoding nucleic acids. inter alia inter alia, a recombinant nucleic acid encoding a respir... |
|
|
Invention
|
Method of lyophilisation. The present invention provides lyophilised pharmaceutical compositions ... |
|
|
Invention
|
Immunogenic composition. The present invention relates to the field of immunogenic compositions a... |
|
|
Invention
|
Analytical method. The present invention relates to liquid chromatography methods (e.g., HPLC) th... |
|
|
Invention
|
Modified meningococcal fhbp polypeptides.
The inventors have identified residues within variant ... |
|
|
G/S
|
Vaccines for human use |
|
|
Invention
|
Modified cytomegalovirus proteins and stabilized complexes.
Described are mutant human cytomegal... |
|
|
Invention
|
Rna formulation. The present invention provides improved RNA-LNP formulations with lower amounts ... |
|
|
Invention
|
Immunogenic composition. The present invention relates to immunogenic compositions comprising Clo... |
|
|
Invention
|
Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of... |
|
|
G/S
|
Pharmaceutical and medicinal preparations and substances; vaccines. |
|
|
Invention
|
Immunisation of large mammals with low doses of rna.
RNA encoding an immunogen is delivered to a... |
|
|
Invention
|
Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells.
The present ... |
|
2023
|
G/S
|
Vaccines. |
|
|
Invention
|
Vaccine.
The present invention is in the field of pneumococcal capsular saccharide conjugate vac... |
|
|
Invention
|
Modified human cytomegalovirus proteins.
Modified HCMV gB proteins in a pre-fusion conformation,... |
|
2022
|
Invention
|
T7 rna polymerase variants for rna synthesis.
The present disclosure provides T7 RNA polymerase ... |
|
|
Invention
|
Ivt rna manufacturing process.
Improved methods for manufacturing a RNA by IVT and compositions ... |
|
|
Invention
|
Shigella vaccine.
The present invention relates to immunogenic compositions and their use in pro... |
|
|
Invention
|
Freeze-drying of lipid nanoparticles (lnps) encapsulating rna and formulations thereof.
Composit... |
|
|
Invention
|
Release assay for determining potency of self-amplifying rna drug product and methods for using. ... |
|
|
Invention
|
Adjuvants.
The present invention relates to immunisation using carrier-formulated mRNA in conjun... |
|
|
Invention
|
Process for bioconjugate production.
The present invention relates to a process for the producti... |
|
|
Invention
|
Therapeutic viral vaccine.
The present invention relates to a HSV2 Fc receptor or immunogenic fr... |
|
2021
|
Invention
|
Self-amplifying messenger rna.
Compounds useful as components of immunogenic compositions for th... |
|
|
Invention
|
Covid-19 vaccines with tocopherol-containing squalene emulsion adjuvants.
Provided are novel vac... |
